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Abstract 
Global endometrial ablation continues to be a 
frequent therapeutic option for abnormal uterine 
bleeding. Post ablation bacteremia, a rare 
clinical occurrence, provides diagnostic and 
treatment challenges for clinicians. We report a 
case of post ablation bacteremia from the 
vaginal flora bacterium Streptococcus 
anginosus. A definition of post ablation 
bacteremia syndrome (PABS) and its clinical 
implications are presented. 
1Northwest Community Hospital, 800 West 
Central Road, Arlington Heights, IL 60005 
Introduction  
Global endometrial ablation may 
introduce endogenous bacterial flora of 
the lower female reproductive tract into 
the bloodstream. Resultant infection 
may be local, regional, or systemic.1 
Pathogenicity of endogenous bacterial 
isolates may vary, effecting the clinical 
course and treatment of patients with 
post ablation bacteremia. Clinicians are 
reminded to consider distant abscess 
formation and metabolic responses to 
sepsis in such cases.2  
Previously, the authors reported a case 
of post ablation bacteremia from 
Gardnerella vaginalis after use of 
intravenous sedation and paracervical 
block.3 We now report a second case of 
post ablation bacteremia from a different 
endogenous bacterium of the lower 
female reproductive tract. In this new 
case, Streptococcus anginosus was the 
isolated bacteremic agent. Adjustments 
in diagnostic testing and antibiotic 
treatment options were required during 
the patient’s course of care. The authors 
propose that post ablation bacteremia 
syndrome is an emerging clinical entity 
of post-operative significance. 
Case Report  
A 40 year old, gravid 2, para 2 
underwent diagnostic hysteroscopy, 
endometrial curettage, and endometrial 
ablation with Novasure device (Cytyc, 
Marlborough, MA, USA) for refractory 
menorrhagia. Intravenous sedation and 
para-cervical block were used at the 
time of the outpatient procedures. 
Povidone-iodine solution was used to 
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prepare the vagina and perineum. 
Sterile technique was maintained 
throughout the case. No immediate 
post-operative complications were 
reported. Perioperative antibiotics were 
not indicated. Endometrial curettings 
from the time of surgery showed benign 
secretory type endometrium. The 
patient’s history was negative for known 
tubal disease or a history of pelvic 
inflammatory disease, and no infectious 
symptoms were reported prior to the 
procedure. Preoperative pap, 
endometrial biopsy, and ultrasound 
were unremarkable for pathologic 
findings.  
The patient presented to the hospital 
emergency department two days after 
her procedures with complaints of fever 
to 100°F and chills which began that 
same day. She denied abdominal pain, 
vaginal bleeding, or dysuria. Her initial 
temperature was 98.8°F (37.1° C). She 
was normotensive with a respiratory rate 
of 20. On examination the abdomen was 
soft, non-tender, non-distended, and 
without guarding, rebound or liver edge 
tenderness. Upon insertion of a 
speculum into the vagina a strong fishy 
odor was encountered and purulent 
discharge was noted at the cervical os. 
Aerobic and anaerobic endocervical 
cultures were obtained. On bimanual 
examination, the cervix and uterus were 
mildly tender. The adnexae were non 
tender and without masses.  
Laboratory findings included a white 
blood cell count of 8,400 cells/mm3, 
neutrophils 91%, lymphocytes 3.6%, 
monocytes 4.8%, hemoglobin 11.9 g/dL, 
platelets 129,000/uL, blood urea 
nitrogen 13 mg/dL, and serum creatinine 
0.77 mg/dL. Blood cultures x 2 sites and 
urine cultures were obtained.  
Vaginal ultrasound of the pelvis showed 
a 9.9 cm x 5.7 cm x 4.8 cm uterus. The 
endometrium measured 5 mm 
endometrium. Fluid and heterogenous 
debris were noted within the endometrial 
cavity. Both ovaries were normal and no 
adnexal masses were seen. The patient 
was admitted for postoperative 
endometritis and begun on intravenous 
ampicillin-sulbactam. Due to malodor of 
the vagina, intravenous metronidazole 
was also initiated.  
The patient was afebrile within 48 hours 
of admission and remained afebrile and 
normotensive for the remainder of her 
hospital stay. However, on the third 
hospital day she complained of bloating, 
decreased appetite and lower 
abdominal pain. Laboratory tests 
(complete blood count, complete 
metabolic profile, coagulation profile) 
and a CT of the abdomen and pelvis 
were ordered given her new symptoms. 
Additionally, that same day, culture 
results returned identifying 
Streptococcus anginosus on aerobic 
endocervical culture and Bacteroides sp 
not fragilis group on anaerobic 
endocervical culture. Furthermore, 
Streptococcus anginosus was isolated 
by polymerase chain reaction from both 
blood cultures samples obtained at the 
time of admission. Urine cultures were 
negative for growth. After identification 
of Streptococcus anginosus as the 
bacteremic agent, intravenous 
ampicillin-sulbactam was continued and 
the intravenous metronidazole was 
discontinued.  
Subsequent laboratory tests on day 3 
were significant for a white blood cell 
count of 5,000 cells/m3, hemoglobin 
10.9 g/dL, platelets 88,000/uL. A normal 
complete metabolic profile and 
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coagulation profile were noted. A 
markedly thickened endometrium was 
noted on CT examination, with no intra-
abdominal or intra-pelvic abscesses, 
retroperitoneal adenopathy, or intra-
peritoneal free fluid noted. Clostridium 
difficile toxin assay was negative. Her 
symptoms readily resolved on day 4. 
The patient was discharged home on 
intravenous ceftriaxone daily for seven 
days on outpatient basis. Her recovery 
after discharge was uneventful. 
Discussion 
Global endometrial ablation is a cost 
effective outpatient/office procedure for 
abnormal uterine bleeding.4 Often 
performed under local or para-cervical 
block and/or intravenous sedation, it 
continues to be a popular therapeutic 
option for both patients and physicians. 
Post ablation infectious complications 
are rare, and may include local 
(endometritis, endomyometritis), 
regional (pelvic, intra- abdominal), or 
distant (brain, liver, lung) sites. 
Bacteremia from endogenous flora of 
the lower female reproductive tract after 
endometrial ablation has been reported 
from mono or poly microbial isolates, 
including Staphylococcus aureus, 
Escherichia coli, Clostridium 
perfringens, Gardnerella vaginalis, 
Granulicatella adiacens, Streptococcus 
agalactiae, Bacteroides fragilis, and 
gram negative bacillus not Bacteroides 
fragilis.1 
Preoperative antibiotic prophylaxis for 
global endometrial ablation is generally 
not recommended by The American 
College of Obstetricians and 
Gynecologists (ACOG), unless the 
patient has a prior history of tubal 
disease, pelvic inflammatory disease, or 
suspected active infection at the time of 
the procedure.5  
In our case, Streptococcus anginosus 
was isolated from endocervical and 
blood culture studies obtained at 
admission. This bacterium is a gram 
positive, non-motile facultative anaerobe 
classified as a sub group of 
Streptococcus viridans.6 First identified 
from a dental abscess in 1956, this 
bacterium is regarded to be an 
endogenous flora of oral, intestinal, and 
vaginal tract sites.7 In vitro cultures 
demonstrate a characteristic caramel or 
butterscotch odor with potentiated 
growth in the presence of acidic 
environments and other bacteria.8,9 
Streptococcus anginosus infections are 
associated with abscess formation due 
to production of hydrolytic enzymes and 
an outer capsule that favors attachment 
to damaged host tissues which also 
resists phagocytosis by cells of the 
host’s immune system.8,9  Primary or 
secondary entry of Streptococcus 
anginosus into the bloodstream after 
endometrial ablation may occur after 
destruction of the endometrial barrier or 
by direct inoculation from para-cervical 
block. Treatment options include 
penicillin, clindamycin, erythromycin, 
vancomycin, or cephalosporin 
antibiotics.8  
Post-operative infection may evoke an 
inflammatory response in the host, 
including fever, hypothermia, 
tachycardia, tachypnea, or a change in 
blood leukocyte count. Systemic 
inflammatory response syndrome 
(SIRS) is identified when two or more of 
those criteria occur in the presence of 
host infection. Progression of infection in 
the host may lead to sepsis, severe 
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sepsis, or septic shock. The continuum 
from sepsis to septic shock increases 
the risk of mortality.10,11 Although many 
cases of patients presenting with SIRS 
may not progress into sepsis or its 
sequela, patients presenting with SIRS 
have a 3.7 times higher proportion of 
bacteremia and 6.9 times higher risk for 
28 day mortality than patients who do 
not have SIRS related findings.10  
Post ablation bacteremia syndrome is a 
rare postoperative infection involving 
entry of vaginal flora bacteria into the 
bloodstream after global endometrial 
ablation. As with SIRS and with PABS 
specifically, presenting symptoms 
include fever, chills, malodorous vaginal 
discharge, or lower abdominal-pelvic 
pain occurring days to weeks after 
surgery. Clinical signs include fever, 
vaginal or cervical discharge, or 
cervical, uterine, adnexal, or generalized 
lower abdominal-pelvic tenderness. 
Diagnosis of post-operative bacteremia 
is confirmed by identification of one or 
more endogenous floral bacteria from 
blood culture. Varied degrees of 
leukocytosis, thrombocytopenia, or left 
white blood cell shift may be noted. CT 
and ultrasound findings may 
demonstrate endometrial fluid with 
debris, or abdominal-pelvic abscess. 
Empiric parenteral antibiotics for 
patients presenting with post ablation 
bacteremia infection include a 
combination of broad spectrum 
antibiotics such as clindamycin (900 mg 
every 8 hours) or metronidazole (500 
mg every 12 hours) plus penicillin (5 
million units every 6 hours) or ampicillin 
(2 grams every 6 hours) plus 
gentamycin (5 mg/kg ideal body weight 
every 24 hours). Aztreonam (2 grams 
every 8 hours) may be substituted for 
gentamycin in renal impaired patients. 
Alternative single agent antibiotics with 
extended antimicrobial coverage may 
also be considered, including extended 
spectrum cephalosporins (cefoxitin, 
cefotetan, cefotaxime, and ceftizoxime), 
extended spectrum penicillin 
(piperacillin-tazobactam), beta-
lactamase inhibitors plus a beta-lactam 
(ticarcillin-clavulanate), and 
carbapenems (ertapenem or 
meropenem).12 
Ongoing patient assessment during 
treatment of post ablation bacteremia 
syndrome is essential during the 
treatment phase as distal site infections 
or abscesses may occur. Initiation of 
broad spectrum antibiotics may require 
modification after specific bacteremic 
agents are identified. Refractory sites of 
local or distal infection may require 
surgical abscess drainage or surgical 
removal of involved organs.  
PABS is rarely encountered in routine 
clinical practice, however its occurrence 
is garnering increasing reports in the 
medical literature.1,2 Progression from 
post-surgical bacteremia, as in PABS, to 
sepsis, severe sepsis, or septic shock 
may be impeded by early recognition 
and parenteral broad spectrum antibiotic 
treatment and should be a recognized 
clinical entity by gynecologic surgeons 
performing endometrial ablation. 
As global endometrial ablations continue 
to increase in volume, it is anticipated 
that clinicians will likely encounter this 
rare infectious disorder.  
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